Displaying drugs 13676 - 13700 of 14496 in total
Lucatumumab
Investigational
Mirostipen
Investigational
Onercept
Investigational
EVT-101
Investigational
Matched Iupac: … 5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methyl-1H-imidazol-1-yl)methyl]pyridazine dihydrochloride …
Methyl-D9-choline
Methyl-D9-choline is under investigation in clinical trial NCT01807910 (ER Stress in NAFLD).
Investigational
Matched Iupac: … (2-hydroxyethyl)tri(2H3)methylazanium …
Matched Description: … Methyl-D9-choline is under investigation in clinical trial NCT01807910 (ER Stress in NAFLD). …
Matched Description: … Methyl-D9-choline is under investigation in clinical trial NCT01807910 (ER Stress in NAFLD). …
Pegteograstim
Pegteograstim is under investigation in clinical trial NCT02787876 (Pegteograstim in Children With Solid Tumors).
Investigational
Matched Description: … Pegteograstim is under investigation in clinical trial NCT02787876 (Pegteograstim in Children With Solid …
Ruplizumab
Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of Antova.
Investigational
Matched Description: … Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of …
NCX 1015
NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory bowel disease (IBD) by NicOx SA.
Investigational
Matched Description: … NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory …
BG-777
BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical studies.
Investigational
Matched Description: … BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical …
TAK-751S
TAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic Escherichia coli.
Investigational
Matched Description: … TAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic _Escherichia …
Ilodecakin
Investigational
Apolizumab
Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.
Investigational
Bivatuzumab
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6. [A31688,A31689]
Investigational
Odiparcil
Investigational
Matched Iupac: … 4-methyl-7-{[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxy}-2H-chromen-2-one …
Pipazethate
A non-narcotic oral antitussive agent.
Experimental
Matched Iupac: … -hexaene-2-carboxylate ... 2-[2-(piperidin-1-yl)ethoxy]ethyl 9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(14),3(8),4,6,10,12 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Refanezumab
Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).
Investigational
Matched Description: … Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke …
Martinostat
Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).
Investigational
Matched Iupac: … (2E)-3-[4-({[(adamantan-1-yl)methyl](methyl)amino}methyl)phenyl]-N-hydroxyprop-2-enamide …
Matched Description: … Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast …
Matched Description: … Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast …
IMG-7289
IMG-7289 is under investigation in clinical trial NCT03136185 (IMG-7289 in Patients With Myelofibrosis).
Investigational
Matched Iupac: … N-[(2S)-5-{[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl] …
Matched Description: … IMG-7289 is under investigation in clinical trial NCT03136185 (IMG-7289 in Patients With Myelofibrosis …
Matched Description: … IMG-7289 is under investigation in clinical trial NCT03136185 (IMG-7289 in Patients With Myelofibrosis …
EMI-137
EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).
Investigational
Matched Description: … EMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections …
ASF-1075
Investigational
OC-1012
OC-1012 is a compound which has emerged as a promising therapeutic agent for the treatment and prevention of mucositis, a serious side effect of chemotherapy and head and neck radiation therapy.
Investigational
Matched Description: … mucositis, a serious side effect of chemotherapy and head and neck radiation therapy. ... 1012 is a compound which has emerged as a promising therapeutic agent for the treatment and prevention of …
PRX-07034
Investigational
Matched Iupac: … N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-2-methanesulfonyl-5-(piperazin-1-yl)aniline hydrochloride …
Pramiconazole
Investigational
Matched Iupac: … }phenyl)piperazin-1-yl]phenyl}-3-(propan-2-yl)imidazolidin-2-one ... 1-{4-[4-(4-{[(2S,4R)-4-(2,4-difluorophenyl)-4-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-2-yl]methoxy …
Sibrotuzumab
Sibrotuzumab is a humanized monoclonal antibody directed against fibroblast activation protein (FAP). It is used to treat cancer.
Investigational
Edifoligide
Investigational
Displaying drugs 13676 - 13700 of 14496 in total